% | $
Quotes you view appear here for quick access.

Titan Pharmaceuticals Inc. Message Board

  • berrygeorge51 berrygeorge51 Jul 20, 2011 6:24 PM Flag

    A question for a pharmaceutical guru.

    What percentage of phase III successful drugs are never approved by the FDA ?

    It must be a small percentage , right ?

    I am assuming that FDA approval is at least at the 90 % range for TTNP. Right or wrong ?

    Comments ? Any stats out there ?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I reckon its not that high. The FDA rejects a fair share of drugs with good data but in a case like this, I would think there is a lot of additional factors weighing in its favor. I reckon the real issues will relate to the safety of putting the device in and taking it out, whether additional safety studies are needed to support the approval, whether the plan for Doctor training is adequate and so on.

    • Only a small percentage of PIII get approved, Titan has made great progress on Probuphine and someone will pay for their success.

      Once we are off the OTCBB exchange, you will see a completly stock

      Here is a link for percent of approval

      • 1 Reply to m_80_mike
      • M_80, that's a great link, thanks.

        I do look at it a little differently. At this point, I would say those numbers argue for a 90% chance of success for Probuphine. It's phase III is already positive and the chances of submitting an NDA are 100%. The numbers do emphasize that Probuphine has already jumped the great majority of statistical hurdles to get where it is today.

        Good luck to all and I must say I'm a little surprised at the PPS. That being said, there is a big difference in market pricing versus NPV. I am sure Sunil and the leadership will go for the best deal possible, whether that is a partnership with a cash upfront payment, sale of foreign rights with subsequent self-funded U.S. NDA or sale of the company outright. I also wish they were on the NADAQ, but such is life.